The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.

In patients with eosinophilic esophagitis, etrasimod led to sustained histologic and endoscopic improvement over a year, with ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...

We may earn commission if you buy from a link. Why Trust Us? Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells.

Get Instant Summarized Text (Gist) Impaired glucose metabolism in glial cells contributes to neurodegeneration associated with tau protein accumulation, as seen in Alzheimer's disease. Enhancing ...

A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof-of-concept ...

GM and LG Energy Solution unveiled the “first-ever” lithium manganese-rich (LMR) prismatic EV battery cells. The new battery cells will be used in upcoming GM EV models, especially trucks and ...